← Astrana Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $44.0m |
$357.7m
+712.16%
|
$519.9m
+45.33%
|
$560.6m
+7.83%
|
$687.2m
+22.58%
|
$773.9m
+12.62%
|
$1.1b
+47.84%
|
$1.4b
+21.19%
|
$2.0b
+46.72%
|
$3.2b
+56.39%
|
$3.8b
+20.82%
|
|
| Cost of Revenue | $254.8m |
$273.5m
+7.33%
|
$361.1m
+32.06%
|
$467.8m
+29.54%
|
$539.2m
+15.26%
|
$596.1m
+10.56%
|
$944.7m
+58.47%
|
$1.2b
+24.03%
|
$1.8b
+50.48%
|
$2.8b
+61.09%
|
$3.4b
+21.19%
|
|
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $254.8m |
$273.5m
+7.33%
|
$361.1m
+32.06%
|
$467.8m
+29.54%
|
$539.2m
+15.26%
|
$596.1m
+10.56%
|
$944.7m
+58.47%
|
$1.2b
+24.03%
|
$1.8b
+50.48%
|
$2.8b
+61.09%
|
$3.4b
+21.19%
|
|
| Gross Profit (Calculated) | ($210.7m) |
$84.3m
+140.00%
|
$158.8m
+88.36%
|
$92.8m
-41.54%
|
$148.0m
+59.43%
|
$177.8m
+20.14%
|
$199.5m
+12.21%
|
$215.0m
+7.76%
|
$271.4m
+26.25%
|
$341.5m
+25.85%
|
— | |
| General and Administrative Expense | $17.0m | $26.4m | $43.4m | $41.5m | $49.1m | $62.1m | $77.7m | $112.6m | $154.1m | $217.3m | $238.5m | |
| Amortization of Intangible Assets | — | — | — | $16.3m | $16.0m | $15.4m | $13.7m | $12.7m | $25.6m | $40.7m | — | |
| Operating Expenses | $51.3m | $322.6m | $431.5m | $528.2m | — | — | — | — | — | — | $3.7b | |
| Operating Income (Loss) | ($7.3m) |
$35.1m
+583.70%
|
$88.4m
+151.61%
|
$32.4m
-63.34%
|
$80.5m
+148.31%
|
$98.2m
+21.96%
|
$104.3m
+6.20%
|
$84.6m
-18.85%
|
$89.3m
+5.60%
|
$78.5m
-12.12%
|
$100.5m
+27.92%
|
|
| Interest Expense, Debt | $183k | — | — | — | — | — | — | — | — | — | $67.3m | |
| Investment Income, Interest | — | $1.0m | $1.3m | $2.0m | $2.8m | $1.6m | $2.0m | $14.2m | $14.5m | $12.2m | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | $2.3m | ($4.1m) | ($146k) | — | — | |
| Gain (Loss) on Investments | — | $13.7m | $0 | $0 | $99.8m | ($10.7m) | ($21.3m) | ($4.6m) | $731k | ($68k) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | ($409k) | ($45k) | $0 | $0 | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | $239k | $168k | $1.6m | $3.0m | $1.1m | ($3.8m) | $3.9m | $6.1m | $4.9m | ($2.8m) | — | |
| Interest Expense (non-operating) | $542k | $80k | $561k | $4.7m | $9.5m | $5.4m | $7.9m | $16.1m | $33.1m | $49.9m | $67.3m | |
| Income (Loss) from Equity Method Investments | — | ($1.1m) | ($8.1m) | ($6.9m) | $3.7m | ($4.3m) | $5.6m | $5.6m | $4.5m | $1.7m | — | |
| Nonoperating Income (Expense) | ($978k) | $14.6m | ($5.8m) | ($6.6m) | $97.9m | ($20.4m) | ($17.6m) | $5.2m | ($8.5m) | ($38.9m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $1.2m | $288k | $49.4m | $3.6m | $84.5m | $77.7m | $86.6m | $89.8m | $80.8m | $39.6m | $60.1m | |
| Current Income Tax Expense (Benefit) | $57k | $24.6m | $30.7m | $15.0m | $62.7m | $34.4m | $55.2m | $44.4m | $35.1m | $19.8m | $20.9m | |
| Income Tax Expense (Benefit) | ($71k) | $3.9m | $22.4m | $8.2m | $56.1m | $28.5m | $40.9m | $32.0m | $30.9m | $15.5m | $20.9m | |
| Net Income (Loss) Attributable to Parent | ($9.3m) |
$25.8m
+376.13%
|
$10.8m
-58.01%
|
$14.1m
+30.29%
|
$37.9m
+168.24%
|
$73.9m
+95.05%
|
$45.2m
-38.84%
|
$60.7m
+34.42%
|
$43.1m
-28.93%
|
$22.5m
-47.89%
|
$40.5m
+80.31%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.2m | $20.0m | $49.4m | $3.6m | $84.5m | ($24.6m) | $570k | ($2.9m) | $6.8m | $1.6m | $40.5m | |
| Earnings Per Share, Basic | $0.46 | $1.01 | $0.33 | $0.41 | $1.04 | $1.69 | $1.00 | $1.30 | $0.91 | $0.46 | $0.83 | |
| Earnings Per Share, Diluted | $0.41 | $0.90 | $0.29 | $0.39 | $1.01 | $1.63 | $0.99 | $1.29 | $0.90 | $0.46 | $0.82 | |
| Weighted Average Number of Shares Outstanding, Basic | — | 25.5m | 32.9m | 34.7m | 36.5m | 43.8m | 45.0m | 46.6m | 47.6m | 49.1m | 49.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 28.7m | 37.9m | 36.4m | 37.4m | 45.4m | 45.6m | 46.9m | 48.0m | 49.4m | 49.5m | |
| Additional Financial Items | ||||||||||||
| Cost, Depreciation and Amortization | — | — | — | — | — | — | $17.5m | $17.7m | $27.9m | $45.7m | — | |
| Costs and Expenses | — | — | — | — | $606.7m | $675.7m | $1.0b | $1.3b | $1.9b | $3.1b | — | |
| Goodwill, Impairment Loss | $546k | — | $3.8m | $3.8m | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | — | — | — | — | $306.6m | $348.3m | $651.8m | $852.9m | $1.3b | $1.9b | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.